Jim Weinstein - Profile and Investment Details

Investor Profile

Jim Weinstein is a Venture Capital, Private Equity Firm based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize, Cardurion Pharmaceuticals, NetRate Systems, Recurly, Armorblox, Amagma Therapeutics, FOLX Health, Kallyope, Vico Therapeutics, Faraday Pharmaceuticals, AgBiome, Metacrine, OM1, Alector, B2Gnow, Freenome, MesodyneMorphic Therapeutic, Adagio Therapeutics, Pandion Therapeutics, Montis Biosciences, Adimab, Candesant Biomedical, ByHeart, Simon Data, Covetrus, Cyclerion Therapeutics, KenSci, Neogene Therapeutics, Lyra Therapeutics, Sesh, Africa Healthcare Network, Gauss Surgical, EGenesis, Wellthy, Tectonic Therapeutic, TARIS Biomedical, Profitero, Automotive Titling Company, Iora Health, ClearSky Data, BlackThorn Therapeutics, Keeps, Scholar Rock, Dewpoint Therapeutics, Foresight Mental Health, Caledonia Spirits, Sonrai Security, Auron Therapeutics, Volastra Therapeutics, Ankyra, Quentis Therapeutics, Drizly, Amunix, Ajax Health, Kronos Bio, FidoCure, SQZ Biotech, Twistlock, Gossamer Bio, Thirty Madison, Dyno Therapeutics, Primmune Therapeutics, Pointy, Lyndra Therapeutics, FloQast, Jnana, SpineZone, Podimetrics, CAMP4 Therapeutics, IconOVir Bio, 1366 Technologies, Falkonry, Tausight, Nomad Health, Allstacks, . Over time, Jim Weinstein has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jim Weinstein is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Patient Care, Health Care, Emerging Technology, Digital Therapeutics, Data Science, Healthcare Delivery, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Health Technology, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Analytics, Technology, Software Development, Software, Biotechnology, Consumer Health, Genomics, Innovation, Neuroscience, Clinical Trials, Consumer Software, Capital Raising, Consulting, Mergers and Acquisitions, Health Diagnostics, Founder-Led VC Investments, Digital Health, Developer Tools, Medical, SaaS, Information Technology, B2B, Software Services, Therapeutics, Health Tech, Machine Learning, Pharmaceuticals, Acquisitions may find it worthwhile to explore potential connections with Jim Weinstein, as their portfolio suggests a familiarity and interest in this area.

Understanding Jim Weinstein’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.